美康生物 (300439.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(美康生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 481,512,053.721,885,869,216.241,470,634,733.00976,807,779.93490,894,873.632,489,086,216.221,901,219,803.891,290,694,224.08577,448,213.25
 营业利润(元) 85,094,634.44279,116,729.59259,653,098.95192,684,195.7376,311,263.10228,640,536.32237,144,032.26170,977,975.3080,741,461.18
 利润总额(元) 86,236,815.74295,679,132.75263,711,661.81192,423,361.9876,474,872.82223,306,336.46233,980,502.38169,552,633.5480,181,917.66
 净利润(元) 78,052,111.07259,499,975.47223,644,277.20169,730,482.2069,653,541.35205,204,421.75199,556,848.25143,869,731.1567,966,450.42
 归属于母公司股东的净利润(元) 79,096,771.20256,551,420.89229,956,759.59174,865,865.2671,413,144.40198,527,038.64203,438,912.53146,545,065.6069,561,237.21
盈利能力:
 销售毛利率(%) 42.2644.6044.8844.4739.4438.1538.1037.3738.32
 销售净利率(%) 16.2113.7615.2117.3814.198.2410.5011.1511.77
 净资产收益率(%) 2.949.828.826.862.86----
 总资产报酬率ROA(%) 2.428.317.225.332.19----
 投入资本回报率ROIC(%) 2.799.118.056.142.527.007.065.132.44
营运能力:
 存货周转率(次) 1.254.383.582.471.29----
 应收账款周转率(次) 0.742.731.821.180.62----
 总资产周转率(次) 0.140.530.410.270.14----
偿债能力:
 资产负债率(%) 19.0122.4324.8125.3625.9929.7030.9232.1331.45
 股东权益比率(%) 81.2677.8175.7675.1174.3370.0469.1767.8768.50
 已获利息倍数(倍) -33.10-170.99-67.75-95.74414.0747.2569.3654.5516.13
 流动比率 3.112.722.472.392.402.112.021.922.02
 速动比率 2.572.232.062.032.041.801.701.611.65
发展能力:
 营业收入增长率(%) -1.91-24.23-22.65-24.32-14.9910.5510.4515.108.70
 营业利润增长率(%) 11.5122.089.4912.70-5.494.0718.4814.43-1.00
 税后利润增长率(%) 10.7629.2313.0319.332.6610.6117.8310.15-7.92
 净资产增长率(%) 8.288.167.287.686.836.957.506.774.95
 总资产增长率(%) -0.95-2.64-2.06-2.69-1.56-0.260.74-3.40-5.42

前瞻产业研究院